RedHill Biopharma Financial Overview
RedHill Biopharma's market cap is currently $3.60M. The company's EPS TTM is $-2.318; its P/E ratio is ―; RedHill Biopharma is scheduled to report earnings on September 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
